Currently, however, only a proportion of cancers have a good response to checkpoint inhibition immunotherapy
Currently, however, only a proportion of cancers have a good response to checkpoint inhibition immunotherapy. a model to study the
Synthesis and Structure–Activity of Wee1 inhibitors
Wee1 inhibitor
Currently, however, only a proportion of cancers have a good response to checkpoint inhibition immunotherapy. a model to study the